Navigation Links
LGE Execs Teams with Texas Tech to License Advancements in Agriculture, Health and Life Sciences
Date:9/3/2008

License agreement with Texas Tech provides veteran business leadership to deliver new ideas to market.

Austin, Texas (PRWEB) September 3, 2008 -- www.lgeexecs.com [LGE Execs], an Austin based firm formed to help companies and organizations grow and succeed, today announced a licensing agreement with the Texas Tech University System (TTUS). The agreement will allow LGE Execs to help commercialize TTUS technologies and innovations, which provide advancements in the agriculture, health and life science industries.

The technology license agreement covers a number of the universities' unique technologies and innovations, including improvements in livestock reproduction and a treatment for Alzheimer's disease. Details on these and other technologies are expected to be disclosed later this year. LGE Execs and TTUS are also evaluating other licensing opportunities in the areas of alternative energy from wind, solar and bio fuels, cancer treatments, nanotechnology, computer sciences, and industrial materials.

"Over the years, our academic leadership has generated a number of advancements that will improve the world around us," said David Miller, Vice Chancellor, Office of Technology Commercialization at the Texas Tech University System. "LGE Execs will provide us with the leadership and business experience needed to bring many promising technologies to the market."

Through the www.lgeexecs.com/technology-transfer.html [Technology Transfer] program, LGE Execs works with dozens of universities and research institutions around the world to evaluate and bring to market commercially viable products that result from the intellectual capital developed in the laboratory or classroom.

Once the products are launched, LGE Execs provides assistance with interim or permanent executives to help manage all aspects of commercialization and business management including staffing, product development, manufacturing, marketing, distribution and fund raising. LGE Execs is currently working with dozens of universities in the U.S. and the U.K to bring their ideas to market.

"LGE Execs has worked with Texas Tech for several months to evaluate the technologies with the greatest market potential and the ability to positively impact the medical and agricultural communities," said Newt Hamlin, a Managing Partner at LGE Execs. "It is our job now to make successful businesses of these brilliant advancements."

As part of its efforts to commercialize the Texas Tech innovations, LGE Execs has begun negotiations for initial funding, mapped out a commercialization strategy and created an executive team to bring these technologies to market once funding has closed. LGE Execs and TTUS plan to include the original inventors in the development of technologies and, whenever possible, have the new companies located in West Texas. This will help grow the regional and local economies and provide fuel for further innovations.

About LGE Execs:
LGE Execs is a group of over 90 seasoned business leaders with executive success running, founding, selling and buying companies or driving divisions and functions for global corporations. LGE Execs works with start-ups, enterprises and universities to assess opportunities or problems, develop strategies and then execute tactics to bring tangible success. LGE Execs is headquartered in Austin, TX, with personnel across the U.S., Europe and Asia. For more information about LGE Execs and the Technology Transfer program, go to www.lgeexecs.com.

About TTUS and the Office of Technology Commercialization:
The Texas Tech University System was created by the Higher Education Coordinating Board in 1996 to expand the educational and research opportunities offered to faculty and students by Texas Tech University and the Texas Tech University Health Sciences Center. Angelo State University joined the System in the summer of 2007.

The System's Office of Technology Commercialization works with university researchers to take their ideas, concepts and/or inventions to the marketplace. Vice Chancellor David L. Miller and his team help to develop start-up companies, assemble an infrastructure to finance proof of concept funding and build relationships with external funding partners. For more on the Office of Technology Commercialization, visit http://www.texastech.edu/otc/.

###

Read the full story at http://www.prweb.com/releases/2008/09/prweb1274964.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related biology technology :

1. Carilion Clinic Invests in Sight Saving Technology to Improve Patient Care: Carilion Clinic Teams Up with Retasure
2. C3i Teams with Oracles Health Sciences Global Business Unit to Provide Customers with Clinical Training and Support Services
3. Touch Bionics adds to sales, marketing, production and design teams
4. Velcura Therapeutics, Inc. Teams with International Discovery Sourcing Consultants to Develop New Therapeutic Molecules for Cancer and Bone Disease
5. Masada Teams With Leading Waste Management Firm to Produce Ethanol From Municipal Solid Waste in the Dominican Republic
6. Communicating Clinical Trial Data: Timing Remains Key Challenge for Marketing Teams
7. Texas Oncology-Baylor Sammons Cancer Center Recognized for Highest Commitment to Clinical Research at ASCO
8. Blue Cross and Blue Shield of Texas Launches an Integrated Medical-Dental Health Program
9. For creating new field of science, Texas chemist wins international prize
10. Texas Boy Receives Wheelchair From New Hampshire Couples Recently Deceased Granddaughter
11. OncoGenex Pharmaceuticals announces out-license of TOCOSOL Paclitaxel to Eagle Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/11/2017)... , ... August 11, 2017 , ... Algenist continues to ... formulation unlocking collagen like never before. , Collagen is the key structural element ... market with Liquid Collagen™, which include: , First to ...
(Date:8/10/2017)... ... August 09, 2017 , ... ... applications in the clinic is here. The team at Capricor Therapeutics, Inc. utilized ... medium for clinical studies. , Dr. Travis Antes, head of analytical development ...
(Date:8/10/2017)... London UK (PRWEB) , ... August 10, 2017 , ... ... host a new educational webinar to demonstrate how Good Clinical Practice (GCP) ... and site documents. In addition the webinar will discuss the importance of GCP compliance, ...
(Date:8/10/2017)... 2017   BioLife Solutions , Inc. (NASDAQ: ... of proprietary clinical grade cell and tissue hypothermic ... or the "Company"), today reported operational highlights and financial ... 30, 2017. Revenue from biopreservation media product ... the second quarter of 2017, an increase of 29% ...
Breaking Biology Technology:
(Date:3/28/2017)... , March 28, 2017 The ... Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, ... Region - Global Forecast to 2022", published by MarketsandMarkets, ... 2016 and is projected to reach USD 75.64 Billion ... and 2022. The base year considered for the study ...
(Date:3/24/2017)... Mar 24, 2017 Research and Markets has ... Market Analysis & Trends - Industry Forecast to 2025" report ... ... at a CAGR of around 15.1% over the next decade to ... report analyzes the market estimates and forecasts for all the given ...
(Date:3/22/2017)... 21, 2017   Neurotechnology , a provider ... today announced the release of the SentiVeillance ... improved facial recognition using up to 10 surveillance, ... computer. The new version uses deep neural-network-based facial ... it utilizes a Graphing Processing Unit (GPU) for ...
Breaking Biology News(10 mins):